Maria Judit Molnar

Maria Judit Molnar MD, PhD, Professor of Neurology, Psychiatry, Clinical Genetics, and Clinical Pharmacology,  Doctor of the Hungarian Academy of Sciences is the director of Semmelweis University’s Institute of Genomic Medicine and Rare Disorders, among others president of the Hungarian Medical College of Clinical Genetics, elected president of the Hungarian Human Genetic Society, Co- Chair of the Neuromuscular Scientific Panel and management board member of the Neurogenetic Scientific Panel of the European Academy of Neurology,  past president of the Hungarian Society of Clinical Neurogenetics, secretary of the Hungarian Society of Personalized Medicine.

She was the vice-rector for Scientific Affairs at Semmelweis University (Budapest, Hungary) between 2012 and 2015, where she was also responsible for International Affairs.

After spending 2 years in Aachen Technische Universitat (Germany) as Humboldt fellow, she has been adjunct professor at the Montreal Neurological Institute, McGill University, between 1999 -2012. She is the member of the steering committee of the Association of Academic Health Centers Internationals. Dr. Molnar is the Facilitator of a Challenge Group of the International Consortia of Personalized Medicine initiated by the European Commission.

Dr. Molnar is recognized as a leading experts on the diagnosis and treatment of neurological and psychiatric disorders. The Institute of Genomic Medicine and Rare Disorders lead by her offers a comprehensive state of the art, patient-centered multidisciplinary care for patients with rare neuropsychiatric disorders including genetic testing, neuropathological investigations and genetic counselling as well. Dr. Molnar’s research covers a broad range of basic and clinical studies on rare neurological disorders, utilizing a broad spectrum of technologies including clinical science, molecular genetics including next generation sequencing and bioinformatics as well. The Institute of Genomic Medicine and Rare Disorders is the part of the European Reference Network of Rare Neurological Disorders (ERN-RND) and Neuromuscular Disorders (ERN-NMD). Dr. Molnar is the member of the management board of the ERN-RND as the work package leader.

She plays important role in the organization of rare disease management in Hungary and acts as an ambassador promoting the personalized healthcare. She is the President of the Advisory Board of Rare Disorders, the official advisory board of the Hungarian Insurance Fund. She is the member of the advisory board of several pharmaceutical companies (AOP Orphan, Biogen, Greenovations Biotech GmbH, Sanofi Aventis, Sarepta, Stealth Health Biotherapeutics). She was the principal investigator of 11 clinical trials, and 13 research grants, published 1 book, 21 book chapters, 140 papers with more than 1500 citations. Hirsch Index is 20. She owns 2 patents. She is active in postgraduate education, 7 PhD students defended their thesis and 5 are active in their education. Several neurologists and clinical geneticist has been trained by her.